APO RESEARCH · REPORT
Piperazine (PIP)
Piperazine (PIP; CAS 110-85-0) is a cyclic ethylene amine with two secondary amine groups. In its pure form, PIP has a freezing point of 106°C and a boiling point of 147°C.
Product & engineering
Understand the product.
Piperazine (PIP; CAS 110-85-0) is a cyclic ethylene amine with two secondary amine groups. In its pure form, PIP has a freezing point of 106°C and a boiling point of 147°C.
Selected research
Market Analysis & Forecast
Global Piperazine (PIP) Market Analysis and Forecast 2026-2032
Market perspective
Piperazine (PIP; CAS 110-85-0) is a cyclic ethylene amine with two secondary amine groups. In its pure form, PIP has a freezing point of 106°C and a boiling point of 147°C.
Global Piperazine (PIP) key players include Akzo Nobel, Dow Chemicals, BASF, etc. Global top three manufacturers hold a share about 40%.
Europe is the largest market, with a share about 25%, followed by North America and China, both have a share about 40 percent.
Read the full market overview
In terms of product, Piperazine Anhydrous is the largest segment, with a share about 75%. And in terms of application, the largest application is Pharmaceutical Industry, followed by Chemical Industry.
This report presents an overview of global market for Piperazine (PIP), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Piperazine (PIP), also provides the consumption of main regions and countries. Of the upcoming market potential for Piperazine (PIP), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Piperazine (PIP) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Piperazine (PIP) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Piperazine (PIP) sales, projected growth trends, production technology, application and end-user industry.
Piperazine (PIP) Segment by Company
Akzo Nobel
Dow Chemicals
BASF
Tosoh
Delamine
Nippon Nyukazai
Diamines And Chemicals Limited (DACL)
Hebei Hejia Pharmaceutical Group
Shaoxing Xingxin New Materials Co.,Ltd
Piperazine (PIP) Segment by Type
Piperazine Anhydrous
68 Piperazine
Others
Piperazine (PIP) Segment by Application
Pharmaceutical Industry
Chemical Industry
Piperazine (PIP) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piperazine (PIP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Piperazine (PIP) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piperazine (PIP).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Piperazine (PIP) production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Sales (consumption), revenue of Piperazine (PIP) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 5: Detailed analysis of Piperazine (PIP) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Piperazine (PIP) sales, revenue, price, gross margin, and recent development, etc.
Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 11: China by type, by application, sales, and revenue for each segment.
Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 15: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Piperazine Anhydrous
- 68 Piperazine
- Others
Applications
- Pharmaceutical Industry
- Chemical Industry
Companies covered
- Akzo Nobel
- Dow Chemicals
- BASF
- Tosoh
- Delamine
- Nippon Nyukazai
- Diamines And Chemicals Limited (DACL)
- Hebei Hejia Pharmaceutical Group
- Shaoxing Xingxin New Materials Co.,Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Piperazine (PIP) Market by Type
- 1.2.1 Global Piperazine (PIP) Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Piperazine Anhydrous
- 1.2.3 68 Piperazine
- 1.2.4 Others
- 1.3 Piperazine (PIP) Market by Application
- 1.3.1 Global Piperazine (PIP) Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Industry
- 1.3.3 Chemical Industry
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Piperazine (PIP) Market Dynamics
- 2.1 Piperazine (PIP) Industry Trends
- 2.2 Piperazine (PIP) Industry Drivers
- 2.3 Piperazine (PIP) Industry Opportunities and Challenges
- 2.4 Piperazine (PIP) Industry Restraints
3 Global Piperazine (PIP) Production Overview
- 3.1 Global Piperazine (PIP) Production Capacity (2021-2032)
- 3.2 Global Piperazine (PIP) Production by Region: 2021 VS 2025 VS 2032
- 3.3 Global Piperazine (PIP) Production by Region
- 3.3.1 Global Piperazine (PIP) Production by Region (2021-2026)
- 3.3.2 Global Piperazine (PIP) Production by Region (2027-2032)
- 3.3.3 Global Piperazine (PIP) Production Market Share by Region (2021-2032)
- 3.4 North America
- 3.5 Europe
- 3.6 China
- 3.7 Japan
4 Global Market Growth Prospects
- 4.1 Global Piperazine (PIP) Revenue Estimates and Forecasts (2021-2032)
- 4.2 Global Piperazine (PIP) Revenue by Region
- 4.2.1 Global Piperazine (PIP) Revenue by Region: 2021 VS 2025 VS 2032
- 4.2.2 Global Piperazine (PIP) Revenue by Region (2021-2026)
- 4.2.3 Global Piperazine (PIP) Revenue by Region (2027-2032)
- 4.2.4 Global Piperazine (PIP) Revenue Market Share by Region (2021-2032)
- 4.3 Global Piperazine (PIP) Sales Estimates and Forecasts 2021-2032
- 4.4 Global Piperazine (PIP) Sales by Region
- 4.4.1 Global Piperazine (PIP) Sales by Region: 2021 VS 2025 VS 2032
- 4.4.2 Global Piperazine (PIP) Sales by Region (2021-2026)
- 4.4.3 Global Piperazine (PIP) Sales by Region (2027-2032)
- 4.4.4 Global Piperazine (PIP) Sales Market Share by Region (2021-2032)
- 4.5 North America
- 4.6 Europe
- 4.7 China
- 4.8 Asia (Excluding China)
- 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
- 5.1 Global Piperazine (PIP) Revenue by Manufacturers
- 5.1.1 Global Piperazine (PIP) Revenue by Manufacturers (2021-2026)
- 5.1.2 Global Piperazine (PIP) Revenue Market Share by Manufacturers (2021-2026)
- 5.1.3 Global Piperazine (PIP) Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 5.2 Global Piperazine (PIP) Sales by Manufacturers
- 5.2.1 Global Piperazine (PIP) Sales by Manufacturers (2021-2026)
- 5.2.2 Global Piperazine (PIP) Sales Market Share by Manufacturers (2021-2026)
- 5.2.3 Global Piperazine (PIP) Manufacturers Sales Share Top 10 and Top 5 in 2025
- 5.3 Global Piperazine (PIP) Sales Price by Manufacturers (2021-2026)
- 5.4 Global Piperazine (PIP) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 5.5 Global Piperazine (PIP) Key Manufacturers Manufacturing Sites & Headquarters
- 5.6 Global Piperazine (PIP) Manufacturers, Product Type & Application
- 5.7 Global Piperazine (PIP) Manufacturers Commercialization Time
- 5.8 Market Competitive Analysis
- 5.8.1 Global Piperazine (PIP) Market CR5 and HHI
- 5.8.2 2025 Piperazine (PIP) Tier 1, Tier 2, and Tier 3
6 Piperazine (PIP) Market by Type
- 6.1 Global Piperazine (PIP) Revenue by Type
- 6.1.1 Global Piperazine (PIP) Revenue by Type (2021-2032) & (US$ Million)
- 6.1.2 Global Piperazine (PIP) Revenue Market Share by Type (2021-2032)
- 6.2 Global Piperazine (PIP) Sales by Type
- 6.2.1 Global Piperazine (PIP) Sales by Type (2021-2032) & (t)
- 6.2.2 Global Piperazine (PIP) Sales Market Share by Type (2021-2032)
- 6.3 Global Piperazine (PIP) Price by Type
7 Piperazine (PIP) Market by Application
- 7.1 Global Piperazine (PIP) Revenue by Application
- 7.1.1 Global Piperazine (PIP) Revenue by Application (2021-2032) & (US$ Million)
- 7.1.2 Global Piperazine (PIP) Revenue Market Share by Application (2021-2032)
- 7.2 Global Piperazine (PIP) Sales by Application
- 7.2.1 Global Piperazine (PIP) Sales by Application (2021-2032) & (t)
- 7.2.2 Global Piperazine (PIP) Sales Market Share by Application (2021-2032)
- 7.3 Global Piperazine (PIP) Price by Application
8 Company Profiles
- 8.1 Akzo Nobel
- 8.1.1 Akzo Nobel Company Information
- 8.1.2 Akzo Nobel Business Overview
- 8.1.3 Akzo Nobel Piperazine (PIP) Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.1.4 Akzo Nobel Piperazine (PIP) Product Portfolio
- 8.1.5 Akzo Nobel Recent Developments
- 8.2 Dow Chemicals
- 8.2.1 Dow Chemicals Company Information
- 8.2.2 Dow Chemicals Business Overview
- 8.2.3 Dow Chemicals Piperazine (PIP) Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.2.4 Dow Chemicals Piperazine (PIP) Product Portfolio
- 8.2.5 Dow Chemicals Recent Developments
- 8.3 BASF
- 8.3.1 BASF Company Information
- 8.3.2 BASF Business Overview
- 8.3.3 BASF Piperazine (PIP) Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.3.4 BASF Piperazine (PIP) Product Portfolio
- 8.3.5 BASF Recent Developments
- 8.4 Tosoh
- 8.4.1 Tosoh Company Information
- 8.4.2 Tosoh Business Overview
- 8.4.3 Tosoh Piperazine (PIP) Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.4.4 Tosoh Piperazine (PIP) Product Portfolio
- 8.4.5 Tosoh Recent Developments
- 8.5 Delamine
- 8.5.1 Delamine Company Information
- 8.5.2 Delamine Business Overview
- 8.5.3 Delamine Piperazine (PIP) Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.5.4 Delamine Piperazine (PIP) Product Portfolio
- 8.5.5 Delamine Recent Developments
- 8.6 Nippon Nyukazai
- 8.6.1 Nippon Nyukazai Company Information
- 8.6.2 Nippon Nyukazai Business Overview
- 8.6.3 Nippon Nyukazai Piperazine (PIP) Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.6.4 Nippon Nyukazai Piperazine (PIP) Product Portfolio
- 8.6.5 Nippon Nyukazai Recent Developments
- 8.7 Diamines And Chemicals Limited (DACL)
- 8.7.1 Diamines And Chemicals Limited (DACL) Company Information
- 8.7.2 Diamines And Chemicals Limited (DACL) Business Overview
- 8.7.3 Diamines And Chemicals Limited (DACL) Piperazine (PIP) Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.7.4 Diamines And Chemicals Limited (DACL) Piperazine (PIP) Product Portfolio
- 8.7.5 Diamines And Chemicals Limited (DACL) Recent Developments
- 8.8 Hebei Hejia Pharmaceutical Group
- 8.8.1 Hebei Hejia Pharmaceutical Group Company Information
- 8.8.2 Hebei Hejia Pharmaceutical Group Business Overview
- 8.8.3 Hebei Hejia Pharmaceutical Group Piperazine (PIP) Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.8.4 Hebei Hejia Pharmaceutical Group Piperazine (PIP) Product Portfolio
- 8.8.5 Hebei Hejia Pharmaceutical Group Recent Developments
- 8.9 Shaoxing Xingxin New Materials Co.,Ltd
- 8.9.1 Shaoxing Xingxin New Materials Co.,Ltd Company Information
- 8.9.2 Shaoxing Xingxin New Materials Co.,Ltd Business Overview
- 8.9.3 Shaoxing Xingxin New Materials Co.,Ltd Piperazine (PIP) Sales, Revenue, Price and Gross Margin (2021-2026)
- 8.9.4 Shaoxing Xingxin New Materials Co.,Ltd Piperazine (PIP) Product Portfolio
- 8.9.5 Shaoxing Xingxin New Materials Co.,Ltd Recent Developments
9 North America
- 9.1 North America Piperazine (PIP) Market Size by Type
- 9.1.1 North America Piperazine (PIP) Revenue by Type (2021-2032)
- 9.1.2 North America Piperazine (PIP) Sales by Type (2021-2032)
- 9.1.3 North America Piperazine (PIP) Price by Type (2021-2032)
- 9.2 North America Piperazine (PIP) Market Size by Application
- 9.2.1 North America Piperazine (PIP) Revenue by Application (2021-2032)
- 9.2.2 North America Piperazine (PIP) Sales by Application (2021-2032)
- 9.2.3 North America Piperazine (PIP) Price by Application (2021-2032)
- 9.3 North America Piperazine (PIP) Market Size by Country
- 9.3.1 North America Piperazine (PIP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 North America Piperazine (PIP) Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 North America Piperazine (PIP) Price by Country (2021-2032)
- 9.3.4 United States
- 9.3.5 Canada
- 9.3.6 Mexico
10 Europe
- 10.1 Europe Piperazine (PIP) Market Size by Type
- 10.1.1 Europe Piperazine (PIP) Revenue by Type (2021-2032)
- 10.1.2 Europe Piperazine (PIP) Sales by Type (2021-2032)
- 10.1.3 Europe Piperazine (PIP) Price by Type (2021-2032)
- 10.2 Europe Piperazine (PIP) Market Size by Application
- 10.2.1 Europe Piperazine (PIP) Revenue by Application (2021-2032)
- 10.2.2 Europe Piperazine (PIP) Sales by Application (2021-2032)
- 10.2.3 Europe Piperazine (PIP) Price by Application (2021-2032)
- 10.3 Europe Piperazine (PIP) Market Size by Country
- 10.3.1 Europe Piperazine (PIP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 10.3.2 Europe Piperazine (PIP) Sales by Country (2021 VS 2025 VS 2032)
- 10.3.3 Europe Piperazine (PIP) Price by Country (2021-2032)
- 10.3.4 Germany
- 10.3.5 France
- 10.3.6 U.K.
- 10.3.7 Italy
- 10.3.8 Russia
- 10.3.9 Spain
- 10.3.10 Netherlands
- 10.3.11 Switzerland
- 10.3.12 Sweden
11 China
- 11.1 China Piperazine (PIP) Market Size by Type
- 11.1.1 China Piperazine (PIP) Revenue by Type (2021-2032)
- 11.1.2 China Piperazine (PIP) Sales by Type (2021-2032)
- 11.1.3 China Piperazine (PIP) Price by Type (2021-2032)
- 11.2 China Piperazine (PIP) Market Size by Application
- 11.2.1 China Piperazine (PIP) Revenue by Application (2021-2032)
- 11.2.2 China Piperazine (PIP) Sales by Application (2021-2032)
- 11.2.3 China Piperazine (PIP) Price by Application (2021-2032)
12 Asia (Excluding China)
- 12.1 Asia Piperazine (PIP) Market Size by Type
- 12.1.1 Asia Piperazine (PIP) Revenue by Type (2021-2032)
- 12.1.2 Asia Piperazine (PIP) Sales by Type (2021-2032)
- 12.1.3 Asia Piperazine (PIP) Price by Type (2021-2032)
- 12.2 Asia Piperazine (PIP) Market Size by Application
- 12.2.1 Asia Piperazine (PIP) Revenue by Application (2021-2032)
- 12.2.2 Asia Piperazine (PIP) Sales by Application (2021-2032)
- 12.2.3 Asia Piperazine (PIP) Price by Application (2021-2032)
- 12.3 Asia Piperazine (PIP) Market Size by Country
- 12.3.1 Asia Piperazine (PIP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 Asia Piperazine (PIP) Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 Asia Piperazine (PIP) Price by Country (2021-2032)
- 12.3.4 Japan
- 12.3.5 South Korea
- 12.3.6 India
- 12.3.7 Australia
- 12.3.8 Taiwan
- 12.3.9 Southeast Asia
13 South America, Middle East and Africa
- 13.1 SAMEA Piperazine (PIP) Market Size by Type
- 13.1.1 SAMEA Piperazine (PIP) Revenue by Type (2021-2032)
- 13.1.2 SAMEA Piperazine (PIP) Sales by Type (2021-2032)
- 13.1.3 SAMEA Piperazine (PIP) Price by Type (2021-2032)
- 13.2 SAMEA Piperazine (PIP) Market Size by Application
- 13.2.1 SAMEA Piperazine (PIP) Revenue by Application (2021-2032)
- 13.2.2 SAMEA Piperazine (PIP) Sales by Application (2021-2032)
- 13.2.3 SAMEA Piperazine (PIP) Price by Application (2021-2032)
- 13.3 SAMEA Piperazine (PIP) Market Size by Country
- 13.3.1 SAMEA Piperazine (PIP) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 13.3.2 SAMEA Piperazine (PIP) Sales by Country (2021 VS 2025 VS 2032)
- 13.3.3 SAMEA Piperazine (PIP) Price by Country (2021-2032)
- 13.3.4 Brazil
- 13.3.5 Argentina
- 13.3.6 Chile
- 13.3.7 Colombia
- 13.3.8 Peru
- 13.3.9 Saudi Arabia
- 13.3.10 Israel
- 13.3.11 UAE
- 13.3.12 Turkey
- 13.3.13 Iran
- 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
- 14.1 Piperazine (PIP) Value Chain Analysis
- 14.1.1 Piperazine (PIP) Key Raw Materials
- 14.1.2 Raw Materials Key Suppliers
- 14.1.3 Manufacturing Cost Structure
- 14.1.4 Piperazine (PIP) Production Mode & Process
- 14.2 Piperazine (PIP) Sales Channels Analysis
- 14.2.1 Direct Comparison with Distribution Share
- 14.2.2 Piperazine (PIP) Distributors
- 14.2.3 Piperazine (PIP) Customers
15 Concluding Insights
16 Appendix
- 16.1 Reasons for Doing This Study
- 16.2 Research Methodology
- 16.3 Research Process
- 16.4 Authors List of This Report
- 16.5 Data Source
- 16.5.1 Secondary Sources
- 16.5.2 Primary Sources
- 16.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst